Document Security Systems Announces Its Impact Bio
Post# of 356
8:02 am ET September 17, 2020 (Benzinga)
ROCHESTER, N.Y., Sept. 17, 2020 (GLOBE NEWSWIRE) -- Document Security Systems, Inc. ("DSS" or the "Company" (NYSESS), a multinational company operating businesses focusing on brand protection technology, blockchain security, direct marketing, healthcare, real estate, and securitized digital assets, today announced its wholly owned subsidiary Impact BioMedical, Inc. ("Impact BioMedical", through its subsidiary Global BioLife, Inc. ("Global BioLife", completed efficacy testing of its proprietary 3F Antiviral Biofragrance ("3F Biofragrance) at a biosafety level 3 containment facility at an independent university. The study demonstrated a 10-fold reduction in COVID-19 viral population on surfaces using 3F Biofragrance.
© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Document Security Systems (DSS) Stock Research Links
Never argue with stupid people, they will drag you down to their level and then beat you with experience.
Get .... PrivacyLok https://cyberidguard.com/
Try SafeVchat: https://cyberidguard.com/
My comments are only my opinion and are not to be used for investment advice.
Please conduct your own due diligence before choosing to buy or sell any stock.